ProPhase Labs, Inc. Share Price
ProPhase Labs, Inc. (PRPH) had Share Price of $0.46 per share as of 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:SharePrice · last filed 2025-11-19
- 2025-09-30: Share Price $0.46.
- 2025-06-30: Share Price $0.40.
- 2025-03-31: Share Price $0.40.
- 2024-09-30: Share Price $2.42.
| Period end | Share Price |
|---|---|
| 2025-09-30 | $0.46 10-Q · filed 2025-11-19 |
| 2025-06-30 | $0.40 10-Q · filed 2025-08-13 |
| 2025-03-31 | $0.40 10-Q · filed 2025-05-20 |
| 2024-09-30 | $2.42 10-Q · filed 2024-11-13 |
| 2024-06-30 | $4.18 10-Q · filed 2024-08-14 |
| 2024-03-31 | $6.47 10-Q · filed 2024-05-10 |
| 2022-09-30 | $9.73 10-Q · filed 2022-11-10 |
| 2022-06-30 | $6.74 10-Q · filed 2022-08-12 |
| 2021-09-30 | $7.48 10-Q · filed 2022-11-10 |
| 2021-06-30 | $9.13 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |